Search Results (586)

Chronic inflammatory skin diseases, including psoriasis, hidradenitis suppurativa (HS), and atopic dermatitis (AD), are increasingly recognized as systemic disorders associated with chronic immune dysregulation. Growing evidence supports their links with metabolic disorders, reflected in heightened interest in therapeutic strategies targeting the immunometabolic axis. This review summarizes current knowledge on the role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the regulation of immune and metabolic processes in chronic inflammatory skin diseases, with particular emphasis on molecular mechanisms and available experimental and clinical data. GLP-1RAs, widely used in the treatment of type 2 diabetes and obesity, may also exhibit anti-inflammatory and immunomodulatory properties beyond their classical metabolic effects. GLP-1 signalling can influence keratinocyte function, immune cell activity, and wound healing. Furthermore, it modulates multiple intracellular signalling pathways, including cAMP/PKA, AMPK, PI3K/Akt, and NF-κB, as well as immune axes such as IL-23/Th17/IL-17 and inflammasome-related signalling. Available evidence suggests that GLP-1RAs may reduce inflammation and disease activity in selected inflammatory dermatoses. However, current evidence remains limited and is based primarily on experimental studies, case reports, and small-scale observational studies. Further well-designed clinical trials are needed to better define the therapeutic potential of GLP-1RAs and their role in dermatological practice. Full article

Reactive oxygen species (ROS) play a dual role in biological systems as indispensable signaling molecules and as key mediators of oxidative damage. Chronic wounds are often associated with excessive ROS formation, which impedes the healing process. Locally applied antioxidants may mitigate such imbalance and support tissue regeneration. The chitosan–hyaluronan (Ch/HA) composite membranes’ biocompatibility, moisture retention, and ability to maintain local redox balance rank these materials among the most promising next-generation wound dressings. The aim of this review is to summarize the Ch/HA composite membranes serving as reservoirs for locally applied antioxidants to accelerate the healing of full-thickness skin wounds in experimental animals. Composite Ch/HA membranes fortified with the selected antioxidants such as phosphatidylcholine dihydroquercetin and glutathione were evaluated in rats. A mitochondria-targeted derivative such as mitoquinone mesylate was evaluated in rats and rabbits, while l-(+)-ergothioneine has been examined in rabbits so far. This review demonstrates that smartly designed Ch/HA composite membranes represent a novel-generation wound dressing platform capable of smart antioxidant release and efficient stimulation of skin regeneration. Full article

Chronic cutaneous wounds and traumatic skin injuries remain a major clinical challenge, characterized by dysregulated healing phases, high susceptibility to microbial infection, and suboptimal response to conventional therapies. Stem cell-derived exosomes (SC-Exos) have emerged as a paradigm-shifting, cell-free nanotherapeutic platform that harnesses the paracrine secretome of stem cells while avoiding the immunological and proliferative complications inherent to direct cell transplantation. Exosomes derived from diverse stem cell sources orchestrate multifactorial wound repair by modulating key cellular signaling cascades and transcriptomic programs that collectively regulate inflammation, angiogenesis, re-epithelialization, extracellular matrix (ECM) remodeling, and scar formation. Beyond their intrinsic regenerative capacity, SC Exos can be engineered using direct strategies (cargo loading, surface modification, biomaterial integration, and conjugation) and indirect approaches (genetic engineering, pretreatment, and preconditioning of parental cells), thereby enabling spatially controlled and temporally sustained exosome release at wound sites with enhanced bioavailability and therapeutic efficacy. In parallel, biomaterial-assisted delivery platforms, including hydrogels, scaffolds, and nanofibers, enhance exosome retention, stability, and controlled-release profiles within the wound microenvironment, thereby further potentiating tissue repair. This review provides a comprehensive overview of recent advances in SC Exos for wound healing and skin regeneration. We first summarize exosome biogenesis, molecular composition, and the distinctive characteristics of exosomes derived from different stem cell sources, along with preclinical evidence supporting their efficacy in cutaneous repair. We then critically examine exosome engineering strategies and biomaterial-integrated delivery systems that augment and fine-tune therapeutic outcomes. Finally, we discuss the current status of clinical trials of SC Exo-based therapies, key manufacturing and regulatory challenges, and future directions for translating these nanoscale, cell-free therapeutics into advanced, personalized wound management. Full article

Chronic wounds remain a major clinical and economic burden due to persistent inflammation, impaired perfusion, microbial biofilms, and dysregulated immune responses that collectively stall epithelialization. Polymicrobial bacterial–fungal biofilms, including Candida species, further delay healing by sustaining inflammation and promoting treatment-resistant infection. Recent advances have accelerated the development of bioengineered skin substitutes, collagen matrices, and placental-derived grafts that modulate macrophage polarization, reactive oxygen species signaling, and extracellular matrix remodeling to restore tissue architecture and promote neovascularization. Their effectiveness, however, depends on integration within structured care pathways that emphasize debridement, moisture balance, and infection control. Artificial intelligence, three-dimensional bioprinting, flexible microelectronic sensors for real-time wound monitoring, and bioactive compounds derived from traditional Chinese medicine, are expanding the therapeutic landscape. Together, these innovations support a shift toward predictive, personalized, and regenerative wound-care strategies. This review aims to provide a mechanistic and clinically contextualized overview of advanced grafting biomaterials, highlighting current applications, limitations, and future directions in chronic wound care. Full article

Background/Objectives: Skin candidiasis is a key contributor to chronic, non-healing wounds, largely due to persistent microbial infections. Candida species can colonize the skin, form protective biofilms, and interfere with enzyme activity, leading to extracellular matrix degradation, changes in pigmentation, and impaired wound healing. The rising prevalence of antifungal resistance challenges its management, underscoring the need for more effective antifungal therapies. Therefore, this study aimed to assess the antifungal effects and wound-healing potential of essential oils (EOs) from Ferulago spp. Methods: The antifungal activity of the EOs from five Ferulago species was evaluated against Candida spp. and Cryptococcus neoformans. The most active EOs were further investigated for their effects on C. albicans virulence factors, including germ tube formation, as well as biofilm formation and disruption. These effects were assessed using microscopic observation, XTT reduction assay, and crystal violet and safranin stainings. The wound-healing potential of the EOs was evaluated using the scratch-wound assay on fibroblasts and keratinocytes. Additionally, the effect on tyrosinase and elastase activity, was also investigated. Results:F. silaifolia and F. cassia essential oils showed fungicidal activity against Candida spp. and Cryptococcus neoformans. F. silaifolia displayed greater potency, with lower MIC and MLC values. Both oils inhibited key C. albicans virulence factors at sub-MIC concentrations. F. silaifolia EO was more effective in preventing biofilm formation whereas F. cassia EO showed notable tyrosinase inhibitory effect. Conclusions: These findings align with traditional uses and suggest that F. silaifolia and F. cassia EOs exhibit antifungal activity alongside properties associated with wound healing, supporting their potential as topical antifungal agents and thereby justifying further investigation. Full article

The treatment of skin diseases remains a significant clinical challenge. Cellulose and its derivatives have emerged as research hotspots in skin-related applications due to their excellent biocompatibility, structural modifiability, and biomimetic properties. This review systematically summarizes the diverse construction forms of cellulose-based materials, including films, nanofibrous scaffolds, hydrogels, and aerogels, with a focus on smart responsive systems tailored to various microenvironmental conditions. Their application progresses in acute/chronic wound healing, bacterial infections, burns, scar prevention, immunomodulation, and smart wearable monitoring are highlighted. The underlying mechanisms involving anti-infection, pro-regeneration, microenvironment modulation, and sensing are analyzed, aiming to provide insights for further exploration of cellulose-based materials in skin disease therapy and even smart wearable devices. Full article

Spinal epidural empyema (SEE) is an uncommon but potentially severe cause of spinal cord compression and neurological dysfunction in veterinary patients. Bite wounds involving the vertebral column may result in deep tissue contamination, paraspinal abscessation, and secondary epidural infection; however, such injuries are poorly described in wildlife species. We report a case of SEE associated with chronically infected bite wounds in an adult Indian crested porcupine (Hystrix indica) with paraplegia. Physical and neurological examinations revealed exudative paravertebral wounds, paraplegia with preserved nociception, and findings consistent with a thoracolumbar spinal cord lesion. Survey radiography and contrast myelography demonstrated an extradural compressive lesion at L1–L2. Surgical exploration revealed a purulent tract extending from the skin and paraspinal tissues into the vertebral canal, and a left L1–L2 hemilaminectomy was performed with drainage, debridement, lavage, and Penrose drain placement. Staphylococcus aureus was isolated from the abscess, and antimicrobial therapy was adjusted based on susceptibility testing. Postoperative management included physiotherapy and environmental modifications to support ambulation. The porcupine regained ambulation within 4 days after surgery and was released back into the wild approximately 50 days postoperatively with normal gait and tail-rattling behaviour. This case highlights bite-wound-associated SEE as an important differential diagnosis in porcupines presenting with paraplegia and draining paraspinal wounds and suggests that surgical decompression combined with prolonged culture-guided antimicrobial therapy and environmental modifications may result in a favourable outcome. Full article

Keloids and hypertrophic scars are fibroproliferative disorders of wound healing characterized by excessive extracellular matrix deposition, constant inflammation, and high recurrence rates despite appropriate management. Conventional therapies, including surgical excision, corticosteroid injections, laser therapy, and radiation, can provide temporary relief. However, treatment failure remains common, specifically in refractory keloids. Recent findings suggest these outcomes cannot be fully explained by technical or mechanical factors alone, and pathological scarring may reflect underlying immune and neuroimmune dysfunction. Current evidence shows prolonged activation of pro-inflammatory and pro-fibrotic cytokine pathways like IL-6, TNF-α, TGF-β, and IL-17 drives sustain fibroblast activation and disrupts normal wound healing and remodeling. Additionally, the skin functions as an integrated neuro-endocrine-immune organ, allowing bidirectional communication between cutaneous nerves, immune cells, and stromal tissue. Neurogenic inflammation is mediated by neuropeptides, mast cell activation, and stress-induced hypothalamic–pituitary–adrenal axis dysregulation, which further amplifies inflammation within scar tissue. Psychiatric comorbidities like depression, anxiety, and chronic psychological stress serve as a positive feedback mechanism and are increasingly recognized as biologically active contributors to immune dysregulation. This review highlights critical gaps in current management strategies and emphasizes the need for biologically informed, multidisciplinary approaches to improve long-term outcomes for keloid and hypertrophic scar management. Full article

The skin represents the largest organ in the body and functions to protect internal tissues from damage and infection. When wounds in small animals do not receive proper management, they may progress to chronic conditions, resulting in pain, delayed healing, and impaired well-being. Although conventional treatment mainly includes the use of topical antimicrobial agents and anti-inflammatory drugs, integrative veterinary medicine has been considered a promising complementary approach to enhance tissue repair. In this context, this study aimed to review non-conventional therapies applied to wound management in small animals, focusing on ozone therapy, light therapy that stimulates cellular activity, herbal medicine, and apitherapy, especially propolis. Overall, the analyzed studies indicate that ozone may contribute to microbial control and modulation of the immune response; light therapy may stimulate cellular activity and collagen production, promoting healing; medicinal plants present antioxidant and anti-inflammatory effects; and propolis demonstrates antimicrobial and regenerative properties. Thus, when responsibly applied and supported by scientific evidence, these approaches may complement conventional therapy, broaden clinical possibilities, and contribute to improved recovery and quality of life in animals. Full article

Chronic wounds resulting from bacterial infection remain one of the main challenges in clinical practice. There is a pressing need to develop an injectable hydrogel sealant with multifunctional properties, including remodeling capabilities, self-healing, painless removal, and antibacterial activity, to promote tissue remodeling. In this work, aldehyde carboxymethylated agarose (ACMA) is employed for the first time as a bio-template. Dopamine (DA) is introduced onto the ACMA template via a reversible Schiff-base reaction, endowing it with biomineralization properties to synthesize DA-modified ACMA-Ag nanoparticles (ACMA-DA-Ag). Further, the prepared ACMA-DA-Ag, which possesses both antibacterial activity and injectable behavior, is incorporated into a guar gum hydrogel through the formation of borate/diol bonds, thereby forming a multiple-dynamic-bond crosslinked network. This hydrogel demonstrates adequate mechanical strength, injectability, remodeling capabilities, and self-healing performance. It can reassemble into a new hydrogel within 4 ± 0.6 min upon simple physical contact, and supports tissue adhesion. Furthermore, the hydrogel effectively covers irregular-shaped wound and can be removed without causing secondary injury. More importantly, this multifunctional hydrogel is cost-effective, easy to synthesize, and simple to use, significantly accelerating skin regeneration and promoting the formation of skin appendages, such as hair follicles. The outcome of this research not only serves a tissue sealant for wound healing, but also presents a new strategy for creating novel polysaccharide-based biomaterials. Full article

Diabetes mellitus affects an estimated 589 million adults globally, and cutaneous manifestations occur in up to 70% of affected individuals during the course of the disease. The objective of this narrative review is to examine the intersection of diabetes mellitus, skin aging, cosmetic dermatologic procedures, and regenerative therapies, with an emphasis on evidence-based best practices and clinical considerations. While the impaired wound healing associated with diabetes has been extensively studied, the aesthetic implications of diabetic skin disease remain comparatively underexplored. Individuals with diabetes frequently exhibit features of accelerated cutaneous aging, including premature wrinkling, dyschromia, xerosis, alopecia, and other cosmetically significant dermatoses that may negatively impact quality of life. In parallel, the demand for aesthetic dermatologic procedures among patients with diabetes has increased substantially; however, evidence-based recommendations guiding the safe and effective use of cosmetic interventions in this population remain limited. Diabetic skin demonstrates accelerated biological aging driven by complex pathophysiological mechanisms, including the accumulation of advanced glycation end products, chronic low-grade inflammation, oxidative stress, microvascular dysfunction, and neuropathy. These processes partially overlap with chronological aging and photoaging but are mechanistically distinct and may influence tissue repair, inflammatory responses, and the safety profile of commonly performed aesthetic procedures such as chemical peels, laser resurfacing, dermal fillers, neuromodulators, and microneedling. Emerging regenerative approaches, including platelet-rich plasma, platelet lysate, and mesenchymal stromal cell-derived products such as exosomes and secretomes, have attracted increasing attention as biologically targeted strategies for cutaneous rejuvenation. Nevertheless, clinical evidence specifically addressing aesthetic interventions in diabetic populations remains limited. A diabetes-informed approach to aesthetic dermatology that considers metabolic status, procedure selection, and post-procedural monitoring is therefore essential to optimize safety and therapeutic outcomes. Full article

Skin aging and wound healing are the result of intricate and interconnected processes involving chronic inflammation, oxidative stress, cellular senescence and extracellular matrix degradation. Mesenchymal stem cell (MSC)-derived exosomes are rich in bioactive components, particularly microRNAs (miRNAs), which play a crucial role in regulating gene expression and key signaling pathways critical for maintaining skin homeostasis. This article reviews the current evidence regarding the roles of MSC-derived exosomal miRNAs (MSC-Exo-miRNAs) in cutaneous repair and rejuvenation. Specific exosomal miRNAs are analyzed for their ability to modulate inflammatory responses, promote fibroblast proliferation and collagen synthesis, enhance angiogenesis, and facilitate keratinocyte migration and re-epithelialization. Their roles in regulating key signaling pathways are discussed in the context of skin regeneration and aging, including nuclear factor-κB (NF-κB), PI3K/Akt, TGF-β/Smad, Wnt/β-catenin, and nuclear factor erythroid 2-related factor 2 (Nrf2). Additionally, emerging engineering strategies aimed at optimizing miRNA cargo loading, improving delivery efficiency, and advancing clinical translation are highlighted. Overall, MSC-Exo-miRNAs represent a promising cell-free therapeutic strategy for skin repair and rejuvenation; however, further mechanistic investigations and rigorous clinical studies are necessary to fully realize their translational potential. Full article

Skin and its appendages form an integrated system of ectodermal mini-organs that rely on Wnt signaling for lifelong homeostasis and regeneration; yet, the pathway operates in a highly organ-specific manner in each compartment. In interfollicular epidermis, the Wnt activity is spatially graded, thus maintaining the balance between basal progenitor proliferation and terminal differentiation. The hair follicle is governed by an intrinsic oscillator based on cross-regulation between Wnt and BMP signaling, providing a cell-autonomous layer of control over hair cycle dynamics. Finally, the nail organ is characterized by the spatial compartmentalization of Wnt activity, with a distal matrix activation zone supported by specialized mesenchymal niche cells that sustain continuous nail plate growth and coordinate the digit tip regeneration. Understanding these divergent regulatory architectures provides a conceptual framework for targeted regenerative strategies aimed at enhancing repair in skin and its appendages. Therefore, in this review, we synthesize recent molecular studies on Wnt signaling in the adult skin, hair follicles, and nail mini-organs, highlighting appendage-specific features that underlie their distinct regenerative capacities. We further discuss how dysregulated Wnt signaling contributes to skin, hair, and nail pathologies such as alopecia, chronic wounds, excessive scarring, skin cancer, and nail deformations, and summarize the emerging strategies that target Wnt pathway to therapeutically enhance hair regrowth, wound repair, cancer treatment, and digit tip regeneration. Full article

The management of complex acute and chronic wounds remains a formidable challenge in modern medicine, underscoring the urgent need for advanced therapeutic strategies that accelerate healing, prevent infection, and promote functional tissue regeneration. Electrospun nanofibers have attracted considerable attention in the biomedical field due to their extracellular matrix-like architecture, high surface area, interconnected porosity, and tunable physicochemical composition, which drive advances in wound regeneration, tissue engineering, and biopolymer-based therapeutics. In wound healing, nanofibrous dressings composed of natural polymers such as chitosan, gelatin, collagen, and cellulose promote cell attachment and proliferation, support angiogenesis, and enable infection control while delivering bioactive agents, thereby addressing significant challenges related to inflammation, biocompatibility, and antimicrobial resistance. In tissue engineering, aligned and hierarchically organized scaffolds fabricated from biopolymers such as collagen, gelatin, chitosan, and cellulose enhance the guided orientation of cells, differentiation, and functional regeneration of neural, musculoskeletal, vascular, and skin tissues. In addition to their conventional regenerative applications, recent studies have demonstrated that electrospun biopolymer nanofibers can be used in multifunctional biomedical platforms, including smart and stimuli-responsive systems for drug delivery, biosensing, regenerative interfaces, and wearable medical technologies. The integrated constructs that incorporate diagnostic or therapeutic functionalities, hybrid fabrication approaches that combine 3D printing with electrospinning, and intelligent biopolymer frameworks that enable telemedicine, real-time physiological monitoring, and personalized regenerative therapies offer new opportunities for developing improved biomedical systems. Overall, these advances position electrospun nanofiber systems as promising biomaterials for next-generation biomedical innovation. This review summarizes recent progress in tissue-engineered scaffolds, wound dressings, fabrication strategies for integrative therapeutics, and wearable devices with transformative potential for biomedical applications. Finally, the review addresses significant challenges related to scalability and clinical translation. It offers perspectives on future directions, including the integration of artificial intelligence and the regeneration of complex skin appendages, which will shape the next generation of nanofiber-based wound-healing therapies. Full article

Chronic wounds represent a significant global healthcare challenge, affecting millions of patients and imposing substantial economic burdens on healthcare systems. Traditional wound management approaches often fail to address the complex pathophysiology underlying chronic wounds, including persistent inflammation, impaired angiogenesis, and disrupted extracellular matrix remodeling. Three-dimensional (3D) bioprinting has emerged as a transformative technology that enables the fabrication of patient-specific, biomimetic tissue constructs capable of addressing these intricate challenges. This comprehensive review synthesizes recent advances in 3D bioprinting for chronic wound treatment, examining bioprinting technologies, biomaterial innovations, mechanisms of wound healing, and clinical applications. Recent studies demonstrate that bioprinted constructs incorporating living cells, growth factors, and bioactive molecules can significantly accelerate wound closure, enhance vascularization, and restore functional skin architecture. Notable innovations include in situ bioprinting systems, photosynthetic scaffolds for oxygen delivery, and immunomodulatory bioinks. While significant technical challenges remain—including vascularization, scalability, and regulatory approval—the integration of advanced bioprinting techniques with regenerative medicine principles offers unprecedented opportunities for personalized chronic wound care and improved patient outcomes. Full article